🏛️ $INJ
STAKING JUST GOT A BROKERAGE TICKER: $INJC
Injective CEO Eric Chen spoke from the NYSE floor about the launch of INJC, the Staked INJ ETF .
The fund gives institutions and everyday investors a way to get exposure to INJ through a brokerage account while the fund handles staking. That means no wallet setup or validator selection for the investor.
But here's the number that actually matters right now:
📊 AUM sits at roughly $16.12M after the first two trading sessions .
⚠️ And the reality check: that figure hasn't moved much from the initial seed — the fund launched with about $15M in net assets, and share count has stayed flat at 600,000 . Early trading volume has been thin, with only 11,931 shares traded on day two . That growth in AUM so far reflects INJ price movement, not new capital flowing in .
The operational details:
🔹 Stakes at least 90% of holdings via validator Luganodes
🔹 1.10% annual management fee, plus a cut of staking rewards
🔹 Staking rewards accrue to NAV rather than being paid out as cash
The number to watch now is how much money the ETF actually attracts.
A $16M fund is a proof of concept, not a demand signal. The real test is whether shares outstanding start climbing — that's when institutional allocation shows up. Until then, INJC is a vehicle waiting for passengers.
Is this the start of real institutional INJ demand, or just a milestone headline? 👇
#İNJ #Injective #INJC #ETF #Crypto #Staking #Institutional #Web3
STAKING JUST GOT A BROKERAGE TICKER: $INJC
Injective CEO Eric Chen spoke from the NYSE floor about the launch of INJC, the Staked INJ ETF .
The fund gives institutions and everyday investors a way to get exposure to INJ through a brokerage account while the fund handles staking. That means no wallet setup or validator selection for the investor.
But here's the number that actually matters right now:
📊 AUM sits at roughly $16.12M after the first two trading sessions .
⚠️ And the reality check: that figure hasn't moved much from the initial seed — the fund launched with about $15M in net assets, and share count has stayed flat at 600,000 . Early trading volume has been thin, with only 11,931 shares traded on day two . That growth in AUM so far reflects INJ price movement, not new capital flowing in .
The operational details:
🔹 Stakes at least 90% of holdings via validator Luganodes
🔹 1.10% annual management fee, plus a cut of staking rewards
🔹 Staking rewards accrue to NAV rather than being paid out as cash
The number to watch now is how much money the ETF actually attracts.
A $16M fund is a proof of concept, not a demand signal. The real test is whether shares outstanding start climbing — that's when institutional allocation shows up. Until then, INJC is a vehicle waiting for passengers.
Is this the start of real institutional INJ demand, or just a milestone headline? 👇
#İNJ #Injective #INJC #ETF #Crypto #Staking #Institutional #Web3
